๐”– Bobbio Scriptorium
โœฆ   LIBER   โœฆ

Management of hepatitis B in liver transplant recipients

โœ Scribed by Carla S. Coffin; Norah A. Terrault


Book ID
108886070
Publisher
John Wiley and Sons
Year
2007
Tongue
English
Weight
77 KB
Volume
14
Category
Article
ISSN
1352-0504

No coin nor oath required. For personal study only.


๐Ÿ“œ SIMILAR VOLUMES


Hepatitis B in liver transplant recipien
โœ Robert G. Gish; Timothy McCashland ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 188 KB ๐Ÿ‘ 1 views

1. The use of low-dose immunosuppressive therapy along with pre- and posttransplantation nucleos(t)ide therapy and posttransplantation hepatitis B immunoglobulin (HBIG) has yielded marked improvements in survival. 2. Lamivudine (Epivir-HBV), adefovir (Hepsera), entecavir (Baraclude), tenofovir (Vire

Ganciclovir treatment of hepatitis B vir
โœ R G Gish; J Y Lau; L Brooks; J W S Fang; S L Steady; J C Imperial; R Garcia-Kenn ๐Ÿ“‚ Article ๐Ÿ“… 1996 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 366 KB ๐Ÿ‘ 2 views

To determine the safety and efficacy of ganciclovir usually experience progressive liver disease over an treatment of hepatitis B virus (HBV) infection after liver accelerated time course and pose a difficult managetransplantation, nine patients (seven males, two females; ment challenge. The treatm

Treatment of hepatitis C in liver transp
โœ Fredric D. Gordon; Paul Kwo; Hugo E. Vargas ๐Ÿ“‚ Article ๐Ÿ“… 2009 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 182 KB ๐Ÿ‘ 1 views

Recurrent hepatitis C after liver transplantation is a universal phenomenon. Graft reinfection occurs rapidly; once it is established, allograft cirrhosis and decompensation rapidly ensue in many patients. Treatment with pegylated interferon plus ribavirin is the standard of care among nontransplant

Treating hepatitis C infection in liver
โœ Norah A. Terrault; Marina Berenguer ๐Ÿ“‚ Article ๐Ÿ“… 2006 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 192 KB ๐Ÿ‘ 1 views

Chronic infection with hepatitis C virus (HCV) is a growing problem worldwide, with up to 300 million individuals infected, and those with chronic infection are at risk for cirrhosis and hepatocellular carcinoma. HCV infection is the most common indication for liver transplantation in the United Sta

Chronic hepatitis E virus infection in l
โœ Elizabeth B. Haagsma; Arie P. van den Berg; Robert J. Porte; Cornelis A. Benne; ๐Ÿ“‚ Article ๐Ÿ“… 2008 ๐Ÿ› John Wiley and Sons ๐ŸŒ English โš– 318 KB ๐Ÿ‘ 1 views

Hepatitis E virus (HEV) infection is known to run a self-limiting course. Sporadic cases of acute hepatitis due to infection with HEV genotype 3, present in pig populations, are increasingly recognized. Zoonotic transmission seems infrequent. The entity of unexplained chronic hepatitis after liver t